Official Site of The State of New Jersey
Self-Reported Prostate Cancer Screening
Summary Indicator Report Data View Options
Self-Reported Prostate Cancer Screening by County, New Jersey, 2017-2020
Why Is This Important?
Prostate cancer is the most commonly occurring form of cancer (excluding skin cancer) among men and is the second leading cause of cancer death for men in New Jersey and the U.S. All men over 40 should visit their doctor for a routine health visit which may include a discussion on prostate health.
Definition
The percentage of men aged 40 and above who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider.
Data Source
Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health(http://www.nj.gov/health/chs/njbrfs/)
How the Measure is Calculated
| Numerator: | The number of men aged 40 and above who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider. |
| Denominator: | The total number of male survey respondents aged 40 or older excluding those who responded "don't know" or "refused" to the numerator question. |
How Are We Doing?
In 2020, about 15% of New Jersey men aged 40 and over reported that a doctor, nurse, or other health professional have talked to them about the advantages and disadvantages of the PSA test.
Available Services
NJDOH has many programs and partnerships related to cancer resources, cancer information and cancer prevention. [http://nj.gov/health/ces/public/resources/ http://nj.gov/health/ces/public/resources/]